T cell receptors (TCRs) can bind to peptides presented by MHC molecules (pMHC) as a first step to trigger a T cell response. Reliable approaches to predict TCR:pMHC binding would have broad applications in clinical diagnostics, therapeutics, and the fundamental understanding of molecular interactions. IMMREP is a community organized series of prediction contests that asks participants to predict TCR:pMHC binding on unpublished datasets. Previous iterations in 2022 and 2023 showed multiple approaches can predict TCR-pMHC binding with significant accuracy (median AUC_0.1≥0.7) for peptides where experimental data is available (“seen” peptides). In contrast, models did not outperform random guessing for peptides that have no such data available (“unseen” peptides). Here we report on the results of IMMREP25, which focused solely on unseen peptides in order to evaluate the cutting edge of the field. We received 126 named submissions predicting the specificity of 1,000 TCRs against twenty unseen peptides restricted by one of two MHC molecules (HLA-A*02:01 and HLA-B*40:01). The best performing methods showed a macro-AUC_0.1 of 0.60, significantly better than random, demonstrating significant advances in the field. The top performing methods incorporated structural modeling into their approach, indicating that especially for ‘unseen’ peptides, a structural understanding aids in the prediction of TCR:pMHC interactions. The results from this benchmark highlight the significant challenges remaining for TCR:pMHC predictions and will inform future method development.
The T cell’s ability to discern self and non-self depends on its T cell receptor (TCR), which recognizes peptides presented by MHC molecules. Understanding this TCR-peptide-MHC (TCRpMHC) interaction is important for cancer immunotherapy design, tissue transplantation, pathogen identification, and autoimmune disease treatments. Understanding the intricacies of TCR recognition, encapsulated in TCRpMHC structures, remains challenging due to the immense diversity of TCRs (>10 8 /individual), rendering experimental determination and general-purpose computational docking impractical. Addressing this gap, we have developed a rapid integrative modeling protocol leveraging unique docking patterns in TCRpMHC complexes. Built upon PIPER, our pipeline significantly cuts down FFT rotation sets, exploiting the consistent polarized docking angle of TCRs at pMHC. Additionally, our ultra-fast structure superimposition tool, GradPose, accelerates clustering. It models a case in 3-4 minutes on 12 CPUs, showcasing a speedup of up to 25-40 times compared to the ClusPro webserver. On a benchmark set of 38 TCRpMHC class I (TCRpMHC-I) complexes, our protocol outperforms the state-of-the-art docking tools in model quality. This protocol can potentially provide structural information to TCR repertoires targeting specific peptides. Its computational efficiency can also enrich existing pMHC-specific single-cell sequencing TCR data, facilitating the development of structure-based deep learning (DL) algorithms. These insights are essential for understanding T cell recognition and specificity, advancing the development of therapeutic interventions.